ACTU logo
ACTU

Actuate Therapeutics Inc

Biotechnology

Actuate Therapeutics Inc (ACTU) Earnings

Last reported
May 15, 2026
EPS estimate
-$0.22
EPS actual
—
Revenue est.
—
Revenue actual
—